DK0683776T3 - Substituerede heteroarylalkylthiopyridiner til bekæmpelse af Helicobacter-bakterier - Google Patents

Substituerede heteroarylalkylthiopyridiner til bekæmpelse af Helicobacter-bakterier

Info

Publication number
DK0683776T3
DK0683776T3 DK94907547T DK94907547T DK0683776T3 DK 0683776 T3 DK0683776 T3 DK 0683776T3 DK 94907547 T DK94907547 T DK 94907547T DK 94907547 T DK94907547 T DK 94907547T DK 0683776 T3 DK0683776 T3 DK 0683776T3
Authority
DK
Denmark
Prior art keywords
heteroarylalkylthiopyridines
pct
substituted
helicobacter bacteria
control helicobacter
Prior art date
Application number
DK94907547T
Other languages
English (en)
Inventor
Bernhard Kohl
Joerg Senn-Bilfinger
Gerhard Grundler
Wolfgang Opferkuch
Original Assignee
Byk Gulden Lomberg Chem Fab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Byk Gulden Lomberg Chem Fab filed Critical Byk Gulden Lomberg Chem Fab
Application granted granted Critical
Publication of DK0683776T3 publication Critical patent/DK0683776T3/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D231/00—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
    • C07D231/02—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
    • C07D231/10—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D231/12—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/56—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, attached to ring carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D249/00—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms
    • C07D249/02—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms not condensed with other rings
    • C07D249/08—1,2,4-Triazoles; Hydrogenated 1,2,4-triazoles
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/14—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing three or more hetero rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing three or more hetero rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing three or more hetero rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing three or more hetero rings

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Communicable Diseases (AREA)
  • Animal Behavior & Ethology (AREA)
  • Oncology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Pyridine Compounds (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
DK94907547T 1993-02-17 1994-02-11 Substituerede heteroarylalkylthiopyridiner til bekæmpelse af Helicobacter-bakterier DK0683776T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
CH50793 1993-02-17
PCT/EP1994/000393 WO1994019346A1 (de) 1993-02-17 1994-02-11 Substituierte heteroarylalkylthiopyridine zur bekämpfung von helicobacter bakterien

Publications (1)

Publication Number Publication Date
DK0683776T3 true DK0683776T3 (da) 1999-10-18

Family

ID=4188595

Family Applications (1)

Application Number Title Priority Date Filing Date
DK94907547T DK0683776T3 (da) 1993-02-17 1994-02-11 Substituerede heteroarylalkylthiopyridiner til bekæmpelse af Helicobacter-bakterier

Country Status (11)

Country Link
US (1) US5587389A (da)
EP (1) EP0683776B1 (da)
JP (1) JPH08507054A (da)
AT (1) ATE178603T1 (da)
AU (1) AU674058B2 (da)
CA (1) CA2156258A1 (da)
DE (1) DE59408087D1 (da)
DK (1) DK0683776T3 (da)
ES (1) ES2132384T3 (da)
GR (1) GR3030288T3 (da)
WO (1) WO1994019346A1 (da)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1995034553A1 (de) * 1994-06-10 1995-12-21 Byk Gulden Lomberg Chemische Fabrik Gmbh Thiopyridine zur bekämpfung von helicobacter-bakterien
CA2192202A1 (en) * 1994-06-10 1995-12-21 Bernhard Kohl Substituted arylalkylthioalkylthiopyridines for use in the control of helicobacter bacteria
AU2923595A (en) * 1994-06-23 1996-01-19 Byk Gulden Lomberg Chemische Fabrik Gmbh 4-s- and n-substituted 6-alkylpyridines for controlling helicobacter bacteria
EP0983263A1 (en) * 1997-05-30 2000-03-08 Dr. Reddy's Research Foundation Novel benzimidazole derivatives as antiulcer agents, process for their preparation and pharmaceutical compositions containing them
DE19745692A1 (de) * 1997-07-24 1999-01-28 Bayer Ag Verfahren zur Herstellung von 2-Chlor-benzimidazol-Derivaten
RU2449805C1 (ru) 2011-01-27 2012-05-10 Общество С Ограниченной Ответственностью "Гармония" Пептидная фармацевтическая композиция, средство на ее основе для лечения гастродуоденальных заболеваний, вызываемых helicobacter pylori, и способ его использования

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS6150978A (ja) * 1984-08-16 1986-03-13 Takeda Chem Ind Ltd ピリジン誘導体およびその製造法
FI90544C (fi) * 1986-11-13 1994-02-25 Eisai Co Ltd Menetelmä lääkeaineina käyttökelpoisten 2-pyridin-2-yyli-metyylitio- ja sulfinyyli-1H-bensimidatsolijohdannaisten valmistamiseksi
WO1992004898A1 (de) * 1990-09-14 1992-04-02 Byk Gulden Lomberg Chemische Fabrik Gmbh Verwendung von pyridylmethylsulfinyl-1h-benzimidazol derivaten zur behandlung durch helicobacter verursachten erkrankungen
EP0567643A4 (en) * 1991-01-16 1995-07-19 Yoshitomi Pharmaceutical NEW PYRIDE DERIVATIVE AND ITS USE AS A SELECTIVE MEDICINAL PRODUCT.
US5504082A (en) * 1992-06-01 1996-04-02 Yoshitomi Pharmaceutical Industries, Ltd. Pyridine compound and pharmaceutical compostions

Also Published As

Publication number Publication date
WO1994019346A1 (de) 1994-09-01
ATE178603T1 (de) 1999-04-15
DE59408087D1 (de) 1999-05-12
EP0683776A1 (de) 1995-11-29
GR3030288T3 (en) 1999-09-30
EP0683776B1 (de) 1999-04-07
AU674058B2 (en) 1996-12-05
ES2132384T3 (es) 1999-08-16
JPH08507054A (ja) 1996-07-30
US5587389A (en) 1996-12-24
AU6108794A (en) 1994-09-14
CA2156258A1 (en) 1994-09-01

Similar Documents

Publication Publication Date Title
NO960514L (no) Substituerte azadioksacykloalkener og deres anvendelse som fungicider
NO962286L (no) N-substituerte azabicykloalkanderivater som neuroleptika etc.
ATE169317T1 (de) Pyridobismidazole enthaltendes rigid-rod-polymer
BR0113162A (pt) Ariloxialquilaminas nao-imidazóis
FI910653A0 (fi) Synteettiset reseptorianalogit
NO962285L (no) N-substituerte azabicykloheptan-derivater anvendt for eksempel som neuroleptika
DE59408087D1 (de) Substituierte heteroarylalkylthiopyridine zur bekämpfung von helicobacter bakterien
ATE203772T1 (de) Markiergen
NO955278D0 (no) Substituerte aryltiolalkyltiopyridiner
DK0695303T3 (da) Hidtil ukendte pyridiniumsalte og deres anvendelse til bekæmpelse af Helicobacter-bakterier
ES2163001T3 (es) Nuevos derivados de borneol, procedimiento para su preparacion y su utilizacion farmaceutica.
ATE207480T1 (de) Substituierte aminoalkylaminopyridine
NO960271L (no) Tiokarbamoylforbindelser anvendt som mikrobiocider
DK0431450T3 (da) 1-brom-3-chlor-1,2-diaryl-2-propanoler, fremgangsmåde til stereoselektiv fremstilling af erythro-1-brom-3-chlor-1,2-diaryl-2-propanoler og deres omsætning til azolylmethyloxiraner

Legal Events

Date Code Title Description
AHB Application shelved due to non-payment